Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: A cost-effectiveness analysis

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 10, 2007, Pages 1371-1377

  Winstead, N S ^a,b   Wilcox, C M ^a  

^a University of Alabama at Birmingham   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN;

ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ESOPHAGOGASTRODUODENOSCOPY; HOSPITAL COST; HOSPITALIZATION; PEPTIC ULCER; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; UPPER GASTROINTESTINAL BLEEDING;

ACUTE DISEASE; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ENDOSCOPY; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COSTS; HUMANS; MALE; PREOPERATIVE CARE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 35748950108     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03516.x     Document Type: Article

References (39)

1. Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointest Endosc 1990 5 (Suppl S8 13.
2. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995 90 : 206 10.
3. Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Bmj 1995 311 : 222 6.
4. Gralnek IM, Jensen DM, Kovacs TO, et al. An economic analysis of patients with active arterial peptic ulcer hemorrhage treated with endoscopic heater probe, injection sclerosis, or surgery in a prospective, randomized trial. Gastrointest Endosc 1997 46 : 105 12.
5. AHRQ. HCUPnet. Available from: http://hcupnet.ahrq.gov [accessed November 2006].
6. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003 98 : 653 9.
7. El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000 95 : 3566 73.
8. Stollman NH, Putcha RV, Neustater BR, Tagle M, Raskin JB, Rogers AI. The uncleared fundal pool in acute upper gastrointestinal bleeding: implications and outcomes. Gastrointest Endosc 1997 46 : 324 7.
9. Cheng CL, Lee CS, Liu NJ, Chen PC, Chiu CT, Wu CS. Overlooked lesions at emergency endoscopy for acute nonvariceal upper gastrointestinal bleeding. Endoscopy 2002 34 : 527 30.
10. Chung YF, Wong WK, Soo KC. Diagnostic failures in endoscopy for acute upper gastrointestinal haemorrhage. Br J Surg 2000 87 : 614 7.
11. Pardo A, Durandez R, Hernandez M, et al. Impact of physician specialty on the cost of nonvariceal upper GI bleeding care. Am J Gastroenterol 2002 97 : 1535 42.
12. Quirk DM, Barry MJ, Aserkoff B, Podolsky DK. Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding. Gastroenterology, 1997 113 : 1443 8.
13. Lee SD, Kearney DJ. A randomized controlled trial of gastric lavage prior to endoscopy for acute upper gastrointestinal bleeding. J Clin Gastroenterol 2004 38 : 861 5.
14. Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol 1989 1 : G470 4.
15. Xu L, Depoortere I, Vertongen P, Waelbroeck M, Robberecht P, Peeters TL. Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor. Biochem Pharmacol, 2005 70 : 879 87.
16. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993 105 : 1886 99.
17. Tack J, Janssens J, Vantrappen G, et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992 103 : 72 9.
18. Weber FH, Jr. Richards RD, McCallum RW. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol 1993 88 : 485 90.
19. Lawrence SP, McNally PR. Intravenous erythromycin to clear the stomach of obstructing clot. Gastrointest Endosc 1994 40 : 774 5.
20. Aubertin JM, Levoir D, Becheur H, Bloch F, Petite JP. Intérêt de l'érythromycine intra-veineuse avant gastroscopie dans les hémorragies digestives hautes. Gastroenterol Clin Biol 1995 19 : 645 6.
21. Nion I, Andant C, Jouet P, Leport J, Soule JC. Intèrít de l'èrythromycine intraveineuse dans la prèparation l'endoscopie en cas d'hêmorragie digestive haute. Gastroenterologie Clinique et Biolique 1998 22 : 554 5.
22. Carbonell N, Pauwels A, Serfaty L, Boelle PY, Becquemont L, Poupon R. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol 2006 101 : 1211 5.
23. Coffin B, Pocard M, Panis Y, et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc 2002 56 : 174 9.
24. Frossard JL, Spahr L, Queneau PE, et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology, 2002 123 : 17 23.
25. Sears R, Duckworth C, Balaban D, et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointest Endosc, 1996 43 : 358.
26. Rudzki S, Czekalowski S, Michalak K, Kusz W, Fularz A. Erytromycyna jako czynnik poprawiaja̧cy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przeqodu pokarmowego. Wiadomości Lekarskie 2006 59 : 490 1.
27. Spiegel BM, Dulai GS, Lim BS, Mann N, Kanwal F, Gralnek IM. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. Clin Gastroenterol Hepatol 2006 4 : 988 97.
28. Spiegel BM, Ofman JJ, Woods K, Vakil NB. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. Am J Gastroenterol 2003 98 : 86 97.
29. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972 7 : 118 33.
30. Ebell MH, Warbasse L, Brenner C. Evaluation of the dyspeptic patient: a cost-utility study. J Fam Pract 1997 44 : 545 55.
31. Groeneveld PW, Lieu TA, Fendrick AM, et al. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol 2001 96 : 338 47.
32. Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis. Aliment Pharmacol Ther 2004 19 : 591 600.
33. Center for Medicare and Medicaid Services Fee Schedule. Available from: http://www.hhs.gov [accessed November 2006].
34. van Zanten AR, Engelfriet PM, van Dillen K, van Veen M, Nuijten MJ, Polderman KH. Importance of nondrug costs of intravenous antibiotic therapy. Crit Care 2003 7 : R184 90.
35. McComb JM, Campbell NP, Cleland J. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol 1984 54 : 922 3.
36. Guelon D, Bedock B, Chartier C, Haberer JP. QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion. Am J Cardiol 1986 58 : 666.
37. Gold MR. Cost-effectiveness in health and medicine. New York : Oxford University Press, 1996 Xxiii : 425p R, Rotondano G, Piscopo R, Bianco MA, D'Angella R, Cipolletta L. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007 102 : 279 89. quiz 469.
38. Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M. Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci 1994 39 : 706 12.
39. Targownik LE, Nabalamba A. Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993-2003. Clin Gastroenterol Hepatol 2006 4 : 1459 66.